Arkolith/Insider Trading/ACAD/Form 4

Thompson Elizabeth H.Z.

EVP, Head of Research & DevACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Jul 31, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$433K
Net Open-Market Flow
-$433K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 30, 2026Sell(S)17K$26.13$431K19K
Jul 30, 2026Sell(S)50$26.17$1K19K
Jul 29, 2026Option exercise(M)32K——36K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 29, 2026Option exercise(M)32K—$032K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001861477-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ACADIA PHARMACEUTICALS INC

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp